On February 9, 2026, Park Ha Biological Technology Co., Ltd. announced a 1-for-50 reverse stock split effective February 20, 2026, reducing its authorized share capital to 3 billion shares. This reverse split was approved on January 29, 2026, and will begin trading on a split-adjusted basis thereafter.